HSBC Holdings’s 10x Genomics TXG Stock Holding History
Bought
Maintained
Sold
Other funds holding TXG
AIM
QCM
NAMA
HSBC Holdings's TXG Position: Q2 2026 in Review
HSBC Holdings increased its 10x Genomics (TXG) stake by 88% in Q2 2026, buying an estimated $6.59M and bringing the position to 537,009 shares worth $20.3M. The position accounts for 0.01% of the portfolio, ranked #759.
HSBC Holdings first reported a position in TXG in Q4 2020 and has held it in 16 quarters since. 393 funds tracked by Wall St. Rank hold TXG as of Q2 2026.
- HSBC Holdings held 537,009 shares of 10x Genomics worth $20.3M as of Q2 2026.
- HSBC Holdings bought 251,620 10x Genomics shares in Q2 2026, an estimated $6.59M.
- 10x Genomics made up 0.01% of HSBC Holdings's portfolio in Q2 2026, its #759 holding.
- HSBC Holdings first reported a position in 10x Genomics in Q4 2020 and has held it in 16 quarters since.
- 393 funds tracked by Wall St. Rank held 10x Genomics as of Q2 2026.
Based on HSBC Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.